Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6314176 | 0.81 | GABRA1 (0.46) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL30657429 | 0.81 | GABRA1 (0.46) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL21132602 | 0.79 | ALDH1A1 (0.37) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL29862003 | 0.79 | ALDH1A1 (0.37) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL23526278 | 0.77 | CYP3A4 (0.45) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL15320312 | 0.77 | CYP3A4 (0.45) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL16962051 | 0.77 | ALDH1A1 (0.36) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL30014285 | 0.77 | CYP3A4 (0.45) | ALDH1A1CYP1A2FAAHCA1CA2 | |
| SCHEMBL17252805 | 0.76 | ACHE (0.39) | ALDH1A1CYP1A2CYP2C9CYP2C19FAAH | |
| SCHEMBL108973 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637449-B2 | Processes for preparing protease inhibitors of hepatitis C virus | MERCK SHARP & DOHME CORP. (US) | 2014-01-28 | — | — | US | disclosed |
| US-8637449-B2 | Processes for preparing protease inhibitors of hepatitis C virus | MERCK SHARP & DOHME CORP. (US) | 2014-01-28 | — | — | US | disclosed |
| US-20120232247-A1 | PROCESSES FOR PREPARING PROTEASE INHIBITORS OF HEPATITIS C VIRUS | MERCK SHARP & DOHME CORP. | 2012-09-13 | — | — | US | disclosed |
| US-20120232247-A1 | PROCESSES FOR PREPARING PROTEASE INHIBITORS OF HEPATITIS C VIRUS | MERCK SHARP & DOHME CORP. | 2012-09-13 | — | — | US | disclosed |
| WO-2011025849-A1 | PROCESSES FOR PREPARING PROTEASE INHIBITORS OF HEPATITIS C VIRUS | MERCK SHARP & DOHME CORP. (US) | 2011-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232247-A1 | PROCESSES FOR PREPARING PROTEASE INHIBITORS OF HEPATITIS C VIRUS | RNASE1, TMPRSS15, HAVCR2 | ALDH1A1 1267/4885CYP1A2 95/4885CYP2C9 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.